This content is in French.
Diagnosis of cancer in patients with rheumatic diseases
4 avril 2024
In patients with chronic rheumatic diseases, misleading symptoms can delay cancer diagnosis. In this study, researchers evaluated whether a metabolic signature could indicate…
Sign in to read the rest
Reserved for healthcare professionals, free registration.
Scientific reference
Karolina Gente et al. Altered serum metabolome as an indicator of paraneoplasia or concomitant cancer in patients with rheumatic disease. Ann Rheum Dis. 2024 Apr 1:ard-2023-224839
View the source
